Literature DB >> 15043511

Review article: current management of alcoholic liver disease.

S Tome1, M R Lucey.   

Abstract

Alcoholic liver disease, including acute alcoholic hepatitis and alcoholic cirrhosis, is a major cause of morbidity and mortality in the Western world. Abstinence remains the cornerstone of management of all forms of alcoholic liver disease. Recent research, which has elucidated the mechanisms of alcohol-induced liver injury, offers the prospect of advances in the management of alcoholic liver disease. We review the most recent data on the efficacy of treatment of acute alcoholic injury, including nutritional support, corticosteroids, anti-inflammatory agents and antioxidants, and agents that are directed against the progression to fibrosis, such as colchicines, propylthiouracil and antioxidants. Although these therapies offer a tantalizing glimpse into a future that may include therapies that directly alter the process of injury and repair in the liver, none has been shown consistently to improve the course of alcoholic liver damage. Consequently, liver transplantation remains an ultimate option for selected patients with liver failure due to chronic alcoholic liver damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043511     DOI: 10.1111/j.1365-2036.2004.01881.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  26 in total

Review 1.  Genetic factors influencing alcohol dependence.

Authors:  R D Mayfield; R A Harris; M A Schuckit
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

2.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

3.  A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis.

Authors:  Ramy Antar; Phil Wong; Peter Ghali
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

Review 4.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?

Authors:  H Tilg; A Kaser
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

6.  Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Archana Rastogi; Chhagan Bihari; Rajan Vijayaraghavan; Vinod Arora; Manoj Kumar Sharma; Shiv Kumar Sarin
Journal:  Virchows Arch       Date:  2018-03-07       Impact factor: 4.064

Review 7.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.

Authors:  Jiu-Cun Wang; Syeling Lai; Xinjian Guo; Xuefeng Zhang; Benoit de Crombrugghe; Sonali Sonnylal; Frank C Arnett; Xiaodong Zhou
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

Review 9.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats.

Authors:  Suchittra Samuhasaneeto; Duangporn Thong-Ngam; Onanong Kulaputana; Doungsamon Suyasunanont; Naruemon Klaikeaw
Journal:  J Biomed Biotechnol       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.